台灣必治妥施貴寶股份有限公司

台灣必治妥施貴寶股份有限公司

2 2 views 4 weeks ago

高級產品經理

Leads Lung Cancer, Renal Cell Carcinoma, and Urothelial Carcinoma in the O+Y portfolio that owns the biggest share of 2027 investment. Calls on chest physicians, thoracic surgeons, urologists, and medical oncologists.…